GPR183
Basic information
Region (hg38): 13:99294539-99307399
Previous symbols: [ "EBI2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR183 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 23 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 1 | 0 |
Variants in GPR183
This is a list of pathogenic ClinVar variants found in the GPR183 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-99295073-G-A | not specified | Likely benign (Oct 03, 2022) | ||
13-99295088-A-G | not specified | Uncertain significance (Jun 25, 2024) | ||
13-99295095-T-C | not specified | Uncertain significance (Mar 01, 2025) | ||
13-99295101-T-C | not specified | Uncertain significance (Mar 08, 2024) | ||
13-99295115-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
13-99295173-G-A | not specified | Uncertain significance (Aug 07, 2024) | ||
13-99295180-C-G | not specified | Uncertain significance (Nov 20, 2024) | ||
13-99295202-T-C | not specified | Uncertain significance (Aug 01, 2024) | ||
13-99295217-A-G | not specified | Uncertain significance (Jun 29, 2023) | ||
13-99295233-G-A | not specified | Uncertain significance (Feb 15, 2025) | ||
13-99295329-G-A | not specified | Uncertain significance (Dec 29, 2024) | ||
13-99295345-A-T | not specified | Uncertain significance (Dec 27, 2023) | ||
13-99295395-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
13-99295580-T-A | not specified | Uncertain significance (Mar 08, 2024) | ||
13-99295656-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
13-99295733-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
13-99295823-G-A | not specified | Uncertain significance (Oct 20, 2024) | ||
13-99295851-T-A | not specified | Uncertain significance (Jan 03, 2024) | ||
13-99295877-T-A | not specified | Uncertain significance (Jan 23, 2024) | ||
13-99295944-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
13-99296007-C-T | not specified | Uncertain significance (Oct 30, 2023) | ||
13-99296025-C-T | not specified | Uncertain significance (Jan 18, 2023) | ||
13-99296045-A-G | not specified | Uncertain significance (Dec 13, 2022) | ||
13-99296048-A-G | not specified | Uncertain significance (Jul 10, 2024) | ||
13-99296060-G-A | not specified | Uncertain significance (Feb 22, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPR183 | protein_coding | protein_coding | ENST00000376414 | 1 | 12876 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0173 | 0.899 | 125729 | 0 | 5 | 125734 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.27 | 153 | 204 | 0.749 | 0.0000107 | 2404 |
Missense in Polyphen | 32 | 80.983 | 0.39514 | 975 | ||
Synonymous | -1.23 | 87 | 73.5 | 1.18 | 0.00000413 | 704 |
Loss of Function | 1.46 | 4 | 8.62 | 0.464 | 4.59e-7 | 115 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000868 | 0.0000868 |
Ashkenazi Jewish | 0.0000999 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000330 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: G-protein coupled receptor expressed in lymphocytes that acts as a chemotactic receptor for B-cells, T-cells, splenic dendritic cells, monocytes/macrophages and astrocytes (By similarity). Receptor for oxysterol 7-alpha,25- dihydroxycholesterol (7-alpha,25-OHC) and other related oxysterols (PubMed:21796212, PubMed:22875855, PubMed:22930711). Mediates cell positioning and movement of a number of cells by binding the 7- alpha,25-OHC ligand that forms a chemotactic gradient (By similarity). Binding of 7-alpha,25-OHC mediates the correct localization of B-cells during humoral immune responses (By similarity). Guides B-cell movement along the B-cell zone-T-cell zone boundary and later to interfollicular and outer follicular regions (By similarity). Its specific expression during B-cell maturation helps position B-cells appropriately for mounting T- dependent antibody responses (By similarity). Collaborates with CXCR5 to mediate B-cell migration; probably by forming a heterodimer with CXCR5 that affects the interaction between of CXCL13 and CXCR5 (PubMed:22913878). Also acts as a chemotactic receptor for some T-cells upon binding to 7-alpha,25-OHC ligand (By similarity). Promotes follicular helper T (Tfh) cells differentiation by positioning activated T-cells at the follicle- T-zone interface, promoting contact of newly activated CD4 T-cells with activated dendritic cells and exposing them to Tfh-cell- promoting inducible costimulator (ICOS) ligand (By similarity). Expression in splenic dendritic cells is required for their homeostasis, localization and ability to induce B- and T-cell responses: GPR183 acts as a chemotactic receptor in dendritic cells that mediates the accumulation of CD4(+) dendritic cells in bridging channels (By similarity). Regulates migration of astrocytes and is involved in communication between astrocytes and macrophages (PubMed:25297897). Promotes osteoclast precursor migration to bone surfaces (By similarity). Signals constitutively through G(i)-alpha, but not G(s)-alpha or G(q)-alpha (PubMed:21673108, PubMed:25297897). Signals constitutively also via MAPK1/3 (ERK1/2) (By similarity). {ECO:0000250|UniProtKB:Q3U6B2, ECO:0000269|PubMed:16540462, ECO:0000269|PubMed:21673108, ECO:0000269|PubMed:21796212, ECO:0000269|PubMed:22875855, ECO:0000269|PubMed:22913878, ECO:0000269|PubMed:22930711, ECO:0000269|PubMed:25297897}.;
- Pathway
- GPCRs, Other;Signaling by GPCR;Signal Transduction;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.332
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.53
Haploinsufficiency Scores
- pHI
- 0.121
- hipred
- N
- hipred_score
- 0.398
- ghis
- 0.534
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.558
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpr183
- Phenotype
- immune system phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- gpr183a
- Affected structure
- ventral wall of dorsal aorta
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- adaptive immune response;mature B cell differentiation involved in immune response;dendritic cell chemotaxis;immune response;humoral immune response;G protein-coupled receptor signaling pathway;T cell chemotaxis;osteoclast differentiation;leukocyte chemotaxis;positive regulation of B cell proliferation;dendritic cell homeostasis;T follicular helper cell differentiation;positive regulation of ERK1 and ERK2 cascade;regulation of astrocyte chemotaxis
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;oxysterol binding